CHEST 2026 attendees can discover recently published research from across the CHEST® journal portfolio during a session featuring presentations from contributing authors and insights from the journals’ editors.
The session Best of CHEST® Journals, Presented by CHEST® Journal, CHEST® Critical Care, and CHEST® Pulmonary will take place at 8 am MST on Monday, October 19, in the Phoenix Convention Center, North Building, Room 228B.
“The shared mission of our journals is to publish clinically relevant research and patient management guidance,” said Matthew Miles, MD, MEd, FCCP, Editor in Chief of CHEST Pulmonary. “Attendees can expect three great articles from which they’re going to hear some really interesting research that supports their clinical practice.”
From CHEST Pulmonary, Emily Wan, MD, will present Safety and Feasibility of a Two-Way Audiovisual Teleconferenced Pulmonary Rehabilitation Program. Pulmonary rehabilitation can provide significant benefits for patients, but clinicians continue to face barriers to getting patients engaged, Dr. Miles said. Dr. Wan’s study investigated whether a virtual program could offer a practical alternative amid limited access to traditional, center-based pulmonary rehabilitation.
“When I saw this research paper, I said, ‘OK, this is close to home. This is something that everybody in pulmonary medicine deals with: How do we get more patients effective pulmonary rehab?’” Dr. Miles said.
Jonathan Taylor, MD, will represent CHEST Critical Care and discuss his study The Use of the ROX Index to Guide High-Flow Nasal Cannula Therapy and the Need for Intubation Is Associated With Meaningful Patient Outcomes. The research offers new insights into the ROX index, a simple calculation incorporating patients’ oxygen saturation, respiratory rate, and the amount of oxygen provided. Researchers retrospectively calculated the ROX index for patients receiving high-flow nasal cannula therapy, then examined outcomes based on whether clinical decisions aligned with the index’s predictions, explained Hayley B. Gershengorn, MD, FCCP, Editor in Chief of CHEST Critical Care.
“Our journal aims to deliver new research that is of value to our clinicians and our patients, both in the ICU and for critical illness at large,” Dr. Gershengorn said. “It’s a nice preliminary step for a study like this to say, ‘When we look back, had we done things differently, we might have seen better outcomes.’”
Kevin Seitz, MD, will discuss the findings from the CHEST journal study Effect of Ventilator Mode on Ventilator-Free Days in Critically Ill Adults: A Randomized Clinical Trial. The trial examined how three standard ventilation modes (volume control, pressure control, and adaptive pressure control) compare in terms of mortality and mechanical ventilation duration in patients who are critically ill. Peter Mazzone, MD, MPH, FCCP, Editor in Chief of the journal CHEST, will provide commentary on the study.
The session is a great opportunity to hear directly from authors and experience the breadth of research across the CHEST journal portfolio, Dr. Gershengorn said.
“I love the diversity of the research that gets presented,” she said. “Some of the most fun sessions as an attendee are when you go to a session and learn something totally outside of your typical area.”
Download the CHEST Events App
Plan your schedule and ensure you don’t miss key CHEST 2026 sessions with the CHEST Events app. The app is your best source of information to ensure that you maximize your experience at the meeting.
